Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

Study provides new insights into genetics and evolution

Researchers from the University of Geneva and the SIB Swiss Institute of Bioinformatics led an analysis of the sequenced genomes of parasitic wasps. Generally unknown to the public, the parasitic wasps kill pest insects. They are like 'smart bombs' that seek out and kill only specific kinds of insects.

19 Jan 2010

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.

19 Jan 2010

New research shows migraine and depression may share common genetic pathways

New research shows that migraine and depression may share a strong genetic component. The research is published in the January 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

18 Jan 2010

Three proteins that lead to memory loss associated with Alzheimer's disease identified

A scientific group led by the Translational Genomics Research Institute (TGen) have identified three kinases, or proteins, that dismantle connections within brain cells, which may lead to memory loss associated with Alzheimer's disease.

18 Jan 2010

Researchers identify ways to predict patients with small-cell lung cancer

Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant to first-line chemotherapy.

18 Jan 2010

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.

13 Jan 2010

Three tumor microRNAs may help identify chemoresistance in small cell lung cancer patients

At least three tumor microRNAs appear to predict when first-line chemotherapy will prove ineffective in some patients with small cell lung cancer, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held Jan. 11-14, 2010.

13 Jan 2010

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

Monsanto Company and Limerick-based biotechnology firm, Stokes Bio Limited, announced today that they have entered into a licensing agreement and R&D collaboration, which is expected to help accelerate the pace of new advancements in plant breeding.

13 Jan 2010

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,’ Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway’s Genetic Health and Ancestry tests.

13 Jan 2010

TD2 and COTI work together to obtain approval of clinical trials for COTI-2

TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.

12 Jan 2010

Sage Bionetworks, Pfizer sign new research partnership to analyze advanced network models of cancer

Sage Bionetworks has announced today a new research partnership with Pfizer, Inc. to build, analyze and exploit advanced network models of cancer. Pfizer will provide research funding to Sage to analyze large, globally coherent datasets from Pfizer, Sage and the public domain.

12 Jan 2010

Researchers identify genetic variant linked with the risk of prostate cancer

Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.

12 Jan 2010

Illumina launches HumanOmniExpress BeadChip for GWAS

Illumina, Inc. today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS).

From Illumina, Inc. 11 Jan 2010

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie.

11 Jan 2010

Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Mirna Therapeutics announced today that the Company received a $5 million award from the State of Texas through the Texas Emerging Technology Fund (“ETF”). The ETF was created with the goal of growing new and existing businesses to accelerate the introduction of new products and services in the marketplace. This is the largest award of this type that has ever been granted.

11 Jan 2010

Renowned physician highlights digital medical devices at International CES 2010

Dr. Eric J. Topol, chief academic officer of Scripps Health and chief medical officer of the West Wireless Health Institute (WWHI), will join Qualcomm chairman and CEO Dr. Paul E. Jacobs during Jacobs' keynote at International CES on Friday, January 8, 2010, to highlight a variety of digital medical devices that offer physicians and consumers the ability to remotely monitor fitness, sleep, vital signs and pre-natal activity.

9 Jan 2010

Study suggests why circumcised men less likely to become infected with HIV

A PLoS One study published Tuesday sheds new light on why men who have been circumcised are less likely to become infected with HIV, ANI/Times of India reports (1/6).

7 Jan 2010

Response Genetics and Genetic Technologies sign exclusive distribution and services agreement

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.

7 Jan 2010

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Agilent Technologies, Inc. (NYSE:A) and Covaris Inc. today announced a co-marketing agreement in which Covaris S2 DNA shearing technology will be marketed with the Agilent SureSelect Target Enrichment System to streamline next-generation sequencing experiments.

6 Jan 2010

Genetic rogue elements could help diagnose breast and bowel cancer

Scientists at The University of Nottingham have found that a group of genetic rogue elements, produced by DNA sequences commonly known as 'junk DNA', could help diagnose breast and bowel cancer.

5 Jan 2010

Genomics News and Research

Further Reading

Study provides new insights into genetics and evolution

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

New research shows migraine and depression may share common genetic pathways

Three proteins that lead to memory loss associated with Alzheimer's disease identified

Researchers identify ways to predict patients with small-cell lung cancer

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

Three tumor microRNAs may help identify chemoresistance in small cell lung cancer patients

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

TD2 and COTI work together to obtain approval of clinical trials for COTI-2

Sage Bionetworks, Pfizer sign new research partnership to analyze advanced network models of cancer

Researchers identify genetic variant linked with the risk of prostate cancer

Illumina launches HumanOmniExpress BeadChip for GWAS

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Renowned physician highlights digital medical devices at International CES 2010

Study suggests why circumcised men less likely to become infected with HIV

Response Genetics and Genetic Technologies sign exclusive distribution and services agreement

Agilent Technologies, Covaris sign co-marketing agreement to streamline next-generation sequencing experiments

Genetic rogue elements could help diagnose breast and bowel cancer

The art of CRISPR: The power and promise of gene editing eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo